NCT04708717 Encoding Temporal Fine Structure for Cochlear Implants
| NCT ID | NCT04708717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2020-09-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to improve music and speech perception for cochlear implant users. Presently, most cochlear implants discard the temporal fine structure of sound, which is information that is widely believed to contribute to both music and speech perception. The proposed work examines perceptual and physiological changes that occur once this information is provided to cochlear implant users in a clear and consistent manner.
Eligibility Criteria
Inclusion Criteria: * Cochlear implant users. Exclusion Criteria: * Younger than 18 years.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04708717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04708717 currently recruiting?
Yes, NCT04708717 is actively recruiting participants. Contact the research team at raymond.goldsworthy@med.usc.edu for enrollment information.
Where is the NCT04708717 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT04708717 clinical trial?
NCT04708717 is sponsored by University of Southern California. The trial plans to enroll 24 participants.